SP-A MOUSE MODELS OF PNEUMOCYSTIS INFECTION

肺孢子虫感染的 SP-A 小鼠模型

基本信息

  • 批准号:
    6537755
  • 负责人:
  • 金额:
    $ 38.25万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2000
  • 资助国家:
    美国
  • 起止时间:
    2000-04-01 至 2005-03-31
  • 项目状态:
    已结题

项目摘要

Pneumocystis carinii (Pc) is a fungus of low virulence that is major cause of pneumonia (P) in HIV patients. Surfactant protein (SP-A), a member of the collectins, plays an important role in the host's innate immunity against pulmonary pathogens. Studies of the interaction of SP-A with Pc have mainly been conducted in vitro and have produced conflicting results. Gene targeted mice deficient in SP-A appear more susceptible to PcP than wild type mice administered the same immunosuppression. The application proposes the following hypotheses: SP-A facilitates the clearance of Pc in the immunocompetent host; this activity can be localized to specific domains of SP-A and is mediated at least in part by alveolar macrophages; SP-A delays the development and reduces the severity of PcP in the immunocompromised host; SP-A down regulates the host immune/inflammatory response to Pc. The specific aims are: 1) To analyze the effects of SP-A on Pc infection in the immunocompetent host. These studies will: 1.1) investigate the effects of SP-A on the clearance of Pc from the lungs; 1.2) determine if the administration of SP-A can reverse the changes in SP-A deficient mice and to localize the specific domains involved; 1.3) study the effects of SP-A on the interaction of Pc with alveolar macrophages; and 1.4) analyze the effects of SP-A on the host immune/inflammatory response to Pc infection. 2) To analyze the effects of SP-A on PcP in the immunocompromised host. These studies will: 2.1) analyze the effects of SP-A on the development of PcP induced by different forms of immunosuppression; 2.2) examine the influence of SP-A on the changes in alveolar cells, sufactant constituents, and lung function that occur with PcP; and 2.3) analyze the influence of SP-A on the host immune/inflammatory response that occurs during the recovery from PcP.
卡氏肺囊虫(Pc)是一种低毒力的真菌,是引起卡氏肺囊虫病的主要原因

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

PETER D WALZER其他文献

PETER D WALZER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('PETER D WALZER', 18)}}的其他基金

Serum Antibodies to Recombinant Pneumocystis Antigens
重组肺孢子虫抗原的血清抗体
  • 批准号:
    7188525
  • 财政年份:
    2005
  • 资助金额:
    $ 38.25万
  • 项目类别:
Serum Antibodies to Recombinant Pneumocystis Antigens
重组肺孢子虫抗原的血清抗体
  • 批准号:
    7585265
  • 财政年份:
    2005
  • 资助金额:
    $ 38.25万
  • 项目类别:
Global Serological Study of Pneumocystis Infection
肺孢子虫感染的全球血清学研究
  • 批准号:
    7114021
  • 财政年份:
    2005
  • 资助金额:
    $ 38.25万
  • 项目类别:
Global Serological Study of Pneumocystis Infection
肺孢子虫感染的全球血清学研究
  • 批准号:
    6934161
  • 财政年份:
    2005
  • 资助金额:
    $ 38.25万
  • 项目类别:
Serum Antibodies to Recombinant Pneumocystis Antigens
重组肺孢子虫抗原的血清抗体
  • 批准号:
    7388815
  • 财政年份:
    2005
  • 资助金额:
    $ 38.25万
  • 项目类别:
SP-A MOUSE MODELS OF PNEUMOCYSTIS INFECTION
肺孢子虫感染的 SP-A 小鼠模型
  • 批准号:
    6077013
  • 财政年份:
    2000
  • 资助金额:
    $ 38.25万
  • 项目类别:
SP-A MOUSE MODELS OF PNEUMOCYSTIS INFECTION
肺孢子虫感染的 SP-A 小鼠模型
  • 批准号:
    6638606
  • 财政年份:
    2000
  • 资助金额:
    $ 38.25万
  • 项目类别:
SP-A MOUSE MODELS OF PNEUMOCYSTIS INFECTION
肺孢子虫感染的 SP-A 小鼠模型
  • 批准号:
    6390669
  • 财政年份:
    2000
  • 资助金额:
    $ 38.25万
  • 项目类别:
SP-A MOUSE MODELS OF PNEUMOCYSTIS INFECTION
肺孢子虫感染的 SP-A 小鼠模型
  • 批准号:
    6735630
  • 财政年份:
    2000
  • 资助金额:
    $ 38.25万
  • 项目类别:
PNEUMOCYSITIS CARINII INFECTION THERAPIES--PRECLIN EVAL
卡氏肺囊虫感染治疗 - PRECLIN 评估
  • 批准号:
    6334487
  • 财政年份:
    1997
  • 资助金额:
    $ 38.25万
  • 项目类别:

相似海外基金

Prevention and Treatment of Pneumocystis Pneumonia
肺孢子虫肺炎的防治
  • 批准号:
    10605177
  • 财政年份:
    2020
  • 资助金额:
    $ 38.25万
  • 项目类别:
Prevention and Treatment of Pneumocystis Pneumonia
肺孢子虫肺炎的防治
  • 批准号:
    10382422
  • 财政年份:
    2020
  • 资助金额:
    $ 38.25万
  • 项目类别:
Development of a vaccine to prevent Pneumocystis pneumonia
开发预防肺孢子虫肺炎的疫苗
  • 批准号:
    9906567
  • 财政年份:
    2020
  • 资助金额:
    $ 38.25万
  • 项目类别:
Pathogenesis of spontaneous pneumocystis pneumonia in Caspase8 and Ripk3 double deficient mice
Caspase8和Ripk3双缺陷小鼠自发性肺孢子虫肺炎的发病机制
  • 批准号:
    19K17650
  • 财政年份:
    2019
  • 资助金额:
    $ 38.25万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Therapeutic antibodies to treat Pneumocystis pneumonia in a nonhuman primate model of HIV infection
在 HIV 感染的非人灵长类动物模型中治疗肺孢子虫肺炎的治疗性抗体
  • 批准号:
    10001636
  • 财政年份:
    2018
  • 资助金额:
    $ 38.25万
  • 项目类别:
Therapeutic antibodies to treat Pneumocystis pneumonia in a nonhuman primate model of HIV infection
在 HIV 感染的非人灵长类动物模型中治疗肺孢子虫肺炎的治疗性抗体
  • 批准号:
    9624861
  • 财政年份:
    2018
  • 资助金额:
    $ 38.25万
  • 项目类别:
Vitamin D as Supplemental Therapy for Pneumocystis Pneumonia
维生素 D 作为肺孢子菌肺炎的补充疗法
  • 批准号:
    9063354
  • 财政年份:
    2016
  • 资助金额:
    $ 38.25万
  • 项目类别:
Vitamin D as Supplemental Therapy for Pneumocystis Pneumonia
维生素 D 作为肺孢子虫肺炎的补充疗法
  • 批准号:
    9238656
  • 财政年份:
    2016
  • 资助金额:
    $ 38.25万
  • 项目类别:
Improved Therapeutics and Diagnostics for Pneumocystis Pneumonia
改进肺孢子虫肺炎的治疗和诊断
  • 批准号:
    10521311
  • 财政年份:
    2016
  • 资助金额:
    $ 38.25万
  • 项目类别:
Improved Therapeutics and Diagnostics for Pneumocystis Pneumonia
改进肺孢子虫肺炎的治疗和诊断
  • 批准号:
    9210593
  • 财政年份:
    2016
  • 资助金额:
    $ 38.25万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了